The cost of health care for children and adults with sickle cell disease

被引:303
|
作者
Kauf, Teresa L. [1 ]
Coates, Thomas D. [2 ]
Liu Huazhi [1 ]
Mody-Patel, Nikita [3 ]
Hartzema, Abraham G. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA
[2] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Ctr Canc & Blood Dis, Los Angeles, CA 90033 USA
[3] Novartis Pharmaceut Inc, Hlth Econ & Outcomes Res, E Hanover, NJ USA
关键词
UNITED-STATES; MANAGED CARE; ANEMIA; HYDROXYUREA; PREVENTION; MORTALITY; ILLNESSES; MEDICAID; LIFE;
D O I
10.1002/ajh.21408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001-2005 to estimate total, SCD-related, and non-SCD-related cost per patient-month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient-month in the 0-9- and 50-64-year age groups, respectively. Average cost per patient-month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non-SCD-related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease. Am. J. Hematol. 84:323-327, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [21] QUALITY OF CARE IN US CHILDREN WITH SICKLE CELL DISEASE
    Washko, Julie Kanter
    Dampier, Carlton
    Agodoa, Irene
    Howard, Robin
    Wade, Sally
    Noxon, Virginia
    Ballas, Samir
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [22] Heterogeneity of respiratory disease in children and young adults with sickle cell disease
    Lunt, Alan
    Mortimer, Lucy
    Rees, David
    Height, Sue
    Thein, Swee Lay
    Greenough, Anne
    THORAX, 2018, 73 (06) : 575 - 577
  • [23] An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost
    Koch, Kathryn L.
    Leonard, Cynthia L.
    Bagemihl, Katherine
    Marks, David
    Abshire, Thomas C.
    Field, Joshua J.
    BLOOD, 2013, 122 (21)
  • [24] A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease
    Pack-Mabien, Ardie
    Haynes, Johnson, Jr.
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (05): : 250 - 257
  • [25] Association Between Episodic Cough and Wheeze and Health Care Utilization in Adults with Sickle Cell Disease
    Agawu, A.
    Nortey, N.
    Jacobs, C.
    Zebrowski, A.
    Lin, M.
    Glassberg, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] The Health Care Transition process for young adults with sickle cell disease: A qualitative assessment.
    Mehta, SR
    Mayhew, DY
    De Leon, JM
    Hartzema, AG
    Lottenberg, R
    BLOOD, 2003, 102 (11) : 495A - 495A
  • [27] Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease
    Calhoun, Cecelia
    Luo, Lingzi
    Baumann, Ana
    James, Aimee
    King, Allison
    BLOOD, 2018, 132
  • [28] Racial centrality and health care use among African American adults with sickle cell disease
    Bediako, Shawn A.
    Lavender, Annette R.
    Yasin, Zahida
    JOURNAL OF BLACK PSYCHOLOGY, 2007, 33 (04) : 422 - 438
  • [29] Cost-Effectiveness of Erythrocytapheresis in Children and Young Adults with Beta Thalassemia Major and Sickle Cell Disease
    Van Hattem, Jessica
    Maes, Philip
    Esterhuizen, Tonya
    De Vos, Ann
    Ruppert, Martin
    van Heerden, Jaques
    BLOOD, 2023, 142
  • [30] Comparing Hearing Loss in Children with Adults Living with Sickle Cell Disease and Sickle Cell Traits
    Ibekwe, T. S.
    Rogers, C.
    Ramma, L.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (01) : 74 - 81